Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 2/20 | 0.34 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19852605 | 0.97 | ADK (0.45) | ADKCASP3MAPTMAPK14MAOA | |
| SCHEMBL23516088 | 0.94 | ADK (0.43) | ADKCASP3MAPTMAPK14HSD17B10 | |
| SCHEMBL23516093 | 0.90 | ADK (0.45) | ADKCASP3MAPTMAPK14MAOA | |
| SCHEMBL19848962 | 0.88 | ADK (0.45) | ADKCASP3MAPTBRD4POLB | |
| SCHEMBL23516108 | 0.86 | HSPA1A (0.41) | MAPTPTGER4POLBKDM4E | |
| SCHEMBL19848848 | 0.86 | NR1H2 (0.43) | CASP3MAPK14HSD17B10POLB | |
| SCHEMBL23516167 | 0.86 | ADK (0.43) | ADKCASP3MAPTBRD4POLB | |
| SCHEMBL23516293 | 0.85 | PDE6D (0.45) | MAPTPOLBKDM4E | |
| SCHEMBL19843492 | 0.85 | POLB (0.39) | CASP3MAPK14HSD17B10POLB | |
| SCHEMBL23516508 | 0.84 | CYP11B2 (0.43) | MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11276825-B2 | Organic molecules for use in organic devices | CYNORA GMBH (DE) | 2022-03-15 | — | — | US | disclosed |
| US-20210184134-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
| EP-3279193-B1 | COMPOUNDS COMPRISING A PHTHALIMIDE GROUP AND CARBAZOLE OR ITS ANALOGUES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-05-08 | — | — | EP | disclosed |
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| WO-2018024723-A1 | PHTHALIMIDE AND CARBAZOLE OR ANALOGS THEREOF CONTAINING COMPOUNDS FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-08 | — | — | WO | disclosed |
| EP-3279193-A1 | COMPOUNDS COMPRISING PHTHALIMIDE AND CARBAZOLE OR ITS ANALOGUES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210184134-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES | CHRM1, C1S, DNMT3L | ADK 3537/4885CASP3 2113/4885MAPT 4763/4885 |
| US-11276825-B2 | Organic molecules for use in organic devices | AOX1, OR10J3, L1CAM | ADK 3298/4885CASP3 2340/4885MAPT 2595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.